Skip to main content

Table 2 Annual health system cost savings associated with avoiding endoscopies in pediatric patients with tTG values >10x ULN (> 200 Chem’U)

From: Value of biopsy in a cohort of children with high-titer celiac serologies: observation of dynamic policy differences between Europe and North America

 

Low Cost ($1881/case)

High Cost ($14,269/case)

NCH Actual Data (73 endoscopies avoided)

$137,313

$1,041,637

US Low Estimate (4891 endoscopies avoided)

$9,199,971

$69,789,679

US High Estimate (7738 endoscopies avoided)

$14,555,178

$110,413,522